Delivering tomorrow’s injectables, today

Injectable therapies are entering a new phase of complexity. Biologics, personalized medicines and combination products are increasing demand for delivery systems that must adapt to more diverse formats and patient needs. Expectations around speed and compliance also continue to rise across the development lifecycle, placing greater pressure on how these systems are designed and scaled.

Purpose-built capabilities for a more complex market

Meeting this demand requires purpose-built capabilities that can support diverse formats, variable batch sizes and evolving regulatory requirements. From early development through to commercial scale, manufacturers are being asked to deliver greater agility without compromising control or quality across sterile injectable manufacturing and advanced delivery programs.

In an article in Drug Development & Delivery, Tommy Schornak, Senior Vice President of Injectables at Kindeva, explores:

• The shift toward personalized therapies and device-integrated formats, such as autoinjectors and microneedle array patches
• The need for flexible infrastructure that can support multiple container types, fill volumes and rapid changeovers
• Rising expectations for automation, data integrity and reduced human intervention in aseptic environments
• The growing importance of early phase collaboration to streamline development and scale up
• A broader industry shift toward injectable CDMO partners structured to solve complex challenges, not simply supply capacity

Building flexibility into injectable manufacturing services

For manufacturers in this space, success depends on aligning infrastructure, expertise and mindset. Facilities must be designed for what comes next, teams must be equipped to adapt quickly and partnerships must be built around shared problem-solving.

This approach creates a stronger foundation for delivering advanced injectable therapies at speed, while maintaining the control and consistency required for global markets.

To explore the full perspective on how to respond to this new era of demand, read the complete article in Drug Development & Delivery here: https://drug-dev.com/injectable-devices-delivering-tomorrows-injectables-to-patients-today-responding-to-a-new-era-of-demand-with-purpose-built-capabilities/